Psychotropic Substances
The 1971 Convention was adopted to limit the diversion and abuse of certain psychotropic substances, such as central nervous stimulants, sedative-hypnotics and hallucinogens, which had resulted in public health and social problems in some countries.
Parties to the 1971 Convention should comply with the dual aim of (i) limiting the use of psychotropic substances to medical and scientific purposes and (ii) ensuring their availability for those purposes.
Governments must provide statistical returns on manufacture, imports and exports of psychotropic substances to INCB on the forms supplied for that purpose. In addition, they should provide complementary information on psychotropic substances, based on recommendations of the Economic and Social Council.
The controls foreseen under the 1971 Convention together with the additional controls required by the Economic and Social Council have significantly reduced the diversion of psychotropic substances. INCB publishes each year information on the licit movement of psychotropic substances in a technical publication.
Recent Updates
- June 2023 - Please use the new Form B/P for submission of assessments. Kindly note that there have been changes in relation to reporting of delta-9-tetrahydrocannabinol. Also, check the new Form B for estimates for narcotic drugs related to cannabis and cannabis resin.
- June 2023 - IDS codes for newly schedule substances now available.
- March 2023 - 2022 Technical Report on Psychotropic Substances now available for download.
- January 2023 - Updated Green List and forms are now available.
Contact the INCB Psychotropics Control Section
Tel: (43 - 1) 26060 - 4277
E-mail:
incb.psychotropics@un.org